NASHVILLE, Tenn., July 12, 2023 /PRNewswire/ -- Cryoport, Inc. (Nasdaq:CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services for the fast growing cell and gene therapy industry, today announced certain preliminary results for second quarter 2023 and updated its expectations for full year 2023 revenue expectations.
Read more at prnewswire.comCryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here